Viewing Study NCT05967754



Ignite Creation Date: 2024-05-06 @ 7:18 PM
Last Modification Date: 2024-10-26 @ 3:04 PM
Study NCT ID: NCT05967754
Status: COMPLETED
Last Update Posted: 2023-08-01
First Post: 2023-07-15

Brief Title: Correlation Between Serum Uric Acid and Pulmonary Hypertension in Obstructive Sleep Apnea Syndrome
Sponsor: Alexandria University
Organization: Alexandria University

Study Overview

Official Title: Correlation Between Serum Uric Acid and Pulmonary Arterial Hypertension Based on Echo Probability in Patients With Obstructive Sleep Apnea Syndrome
Status: COMPLETED
Status Verified Date: 2023-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aimed to correlate serum uric acid levels and PAH in OSAHS patients
Detailed Description: Obstructive sleep apnea-hypopnea syndrome is the most common form of SRBDs Recurrent hypoxia that accompanies OSAHS increases the degradation of ATP which in turn increase uric acid concentration that can be used as a biomarker of tissue hypoxia in OSAHS There is still debate about whether OSAHS is an independent contributor to pulmonary arterial hypertension

AIM OF THE WORK This study aimed to correlate serum uric acid levels and PAH in OSAHS patients Methods We enrolled 100 patients diagnosed with OSAHS using polysomnography Patients were divided into three severity groups mild OSA 5 AHI 15 moderate OSA 15 AHI 30 and severe 30 AHI 60 Serum uric acid was measured the morning after polysomnography All patients underwent standard echocardiograms and Pulmonary artery systolic pressure calculation was done

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None